Online Only Articles

Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma

Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Department of Hematology, Wrocław Medical University, Wrocław, Poland
Department of Hematology, Wrocław Medical University, Wrocław, Poland
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2019.233189